Non-Small Cell Lung Carcinoma Advanced Local TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging | Chemotherapy | Chemoradiotherapy | Recurrent disease
Item
subject has locally advanced or metastatic stage iiib/iv non-small cell lung cancer that has relapsed after chemotherapy/chemoratiotherapy.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C0436307 (UMLS CUI [4])
C0277556 (UMLS CUI [5])
Chemotherapy Quantity Recurrent disease | Chemotherapy Quantity Neoplasm Metastasis
Item
subject has had at least one chemotherapy regimen for recurrent or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
Age
Item
subject is 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
subject has a performance status of 0-2 on ecog scale.
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative
Item
women of childbearing potential have a negative pregnancy test
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Chemotherapy | Biological treatment | bevacizumab
Item
subject has had chemotherapy within 2 weeks or biological therapy (e.g. bevacizumab) within 4 weeks
boolean
C0392920 (UMLS CUI [1])
C1531518 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
Adverse event Due to Prior Therapy | Recovery Lacking
Item
subject has not recovered from adverse events from previous therapy within 4 weeks
boolean
C0877248 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
EGFR-TK inhibitor | Anti-EGFR Antibody
Item
subject has received egfr-tki inhibitor/anti-egfr mab therapy
boolean
C1443775 (UMLS CUI [1])
C4055105 (UMLS CUI [2])
IGF1R | Other Coding
Item
subject has received igf1r-tki inhibitor/anti-igf1r mab therapy
boolean
C0140080 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
Systemic Chemotherapy Quantity Neoplasm Metastasis
Item
subject has had more than 2 systemic chemotherapies for metastatic disease
boolean
C1883256 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Therapeutic radiology procedure Completion Lacking | Toxicity Resolution Lacking
Item
subject has not completed radiotherapy with complete resolution of toxicities at least 2 weeks before starting in the study
boolean
C1522449 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0600688 (UMLS CUI [2,1])
C1514893 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Study Subject Participation Status
Item
subject is taking part in another clinical study
boolean
C2348568 (UMLS CUI [1])
Central Nervous System Neoplasms, Primary
Item
subject has a primary central nervous system tumor
boolean
C0751620 (UMLS CUI [1])
Substance Use Disorders
Item
subject abuses drugs or alcohol
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
subject is pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
subject is hiv positive
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
subject has a history of hepatitis b or c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Growth Hormone | Growth Hormone Receptor Inhibitor
Item
subject is using growth hormone or growth hormone inhibitors
boolean
C0037663 (UMLS CUI [1])
C3812146 (UMLS CUI [2])